In further testing, a significant interaction between Ki67 tumor expression (cut-off 15%) and multimodality treatment vs. other therapy options (interaction term, p = 0.031) was found, indicating a predictive relationship between Ki67 expression and multimodality treatment. Here, MKI67 is linked to neoplasm.